Skip to content
Sign in
Health · Global

Swimmer Archie Goodburn says doctors first diagnosed him with migraine before brain cancer discovery

Archie Goodburn told Brain Tumour Research that he was initially told he had a migraine before he was diagnosed with an oligodendroglioma. He said the cancer was described to him as incurable with a 10 to 12 year prognosis and that he began taking vorasidenib in summer 2025, which he called "transformational."

AI-assisted synthesis · Based on 4 outlets' reporting · Full text read from 2 of 4 outletsHow it's made

4 outletsLatest reporting 4 min read
Coverage: Mostly CenterL 1 · C 2 · R 0 · 1 unrated

What happened

Key facts

  • Archie Goodburn said he was told he had a migraine before his later cancer diagnosis (per dailyrecord.co.uk).
  • Archie Goodburn was diagnosed with an oligodendroglioma at age 22 (per The Independent).
  • Archie Goodburn said doctors told him he had incurable cancer and gave a prognosis of 10 to 12 years to live (per dailyrecord.co.uk, The Independent).
  • Goodburn said he paid for a private MRI while training for the 2024 Olympic trials (per The Independent).
  • Goodburn is due to meet the Prime Minister following an emotional appeal on BBC Breakfast (per dailyrecord.co.uk).
  • Goodburn called for the Prime Minister to establish a national brain cancer lead (per dailyrecord.co.uk).

The brief

Archie Goodburn, a 25-year-old Scottish swimmer, says he was initially told he had a migraine before being diagnosed with an oligodendroglioma at 22. Goodburn has described learning he had incurable brain cancer and being given a prognosis of 10 to 12 years to live, an assessment he told Brain Tumour Research left him devastated.

He said he paid for a private MRI while preparing for the 2024 Olympic trials, a scan that led to the cancer diagnosis. Goodburn has appealed publicly for greater action on brain tumours and is due to meet the Prime Minister after an emotional appearance on BBC Breakfast, according to the reporting.

He urged the Prime Minister to create a national brain cancer lead, arguing that trials available elsewhere are not sufficiently accessible in the UK. Headlines from the BBC and STV confirm plans for the meeting.

On treatment, Goodburn said he began taking vorasidenib in summer 2025 and described the drug's effect as "transformational." He warned that if vorasidenib fails there is no clear "plan B" or next line of treatment available in the country, a point he made in remarks carried by the press.

Both Daily Record and The Independent carried his comments about the lack of further treatment options being available in the UK. Goodburn has emphasised the personal impact of the diagnosis, asking how a man in his 20s should plan a decade of life after being told he has limited time.

His account combines a critique of national research and treatment access with a call for political action; he has sought to use his public profile to press for a named government role coordinating brain cancer work.

Reporting frames differ slightly: tabloid coverage highlights the emotional and personal angle of Goodburn's story and the appeal to the Prime Minister, while broadsheets provide more detail on diagnosis timing and treatment name.

All direct quotes and medical details in this brief are drawn from Goodburn's statements to Brain Tumour Research as reported by the supplied outlets.

This account does not attempt to adjudicate clinical decisions that preceded Goodburn's diagnosis; the sources report his statement that he was first told he had a migraine but do not present medical records or a treating clinician's explanation of the earlier assessment.

The sources also do not provide independent confirmation of available alternative treatments in the UK beyond Goodburn's statement about the absence of a "plan B."

Why it matters

  • Patients with brain tumours in the UK: Archie Goodburn’s account identifies a specific mechanism of harm — delayed diagnosis after an initial migraine assessment — that affected his ability to access earlier care and altered his treatment pathway.
  • Treatment access and continuity: Goodburn’s statement that vorasidenib is his current therapy and that no further approved options exist in the UK documents a concrete clinical gap for people with the same tumour type.
  • Policy and research coordination: Goodburn’s call for a national brain cancer lead highlights a documented interest by him and Brain Tumour Research in a named government role to improve trial access and treatment pathways.

What to watch next

  • Whether the Prime Minister meets Archie Goodburn as reported in the press and whether that meeting results in a government announcement about creating a national brain cancer lead.
  • Whether the UK government or the Department of Health issues a statement or policy proposal addressing access to trials or alternative treatment pathways for oligodendroglioma patients following Goodburn’s appeal.
  • Whether further reporting provides medical records or clinician statements clarifying why Goodburn was initially told he had a migraine and what diagnostic steps followed the private MRI.

How it's being covered

Coverage analysisShow details
5 source articles · 4 unique outlets
Coverage mix: Mostly Center· 1 Left · 2 Center
Where the outlets are based: Europe 100%
Coverage mix
Mostly Center
Left
Center
Right
1 outlet
2 outlets
0 outlets
The marker shows coverage balance: each unique outlet counts once. 1 unrated outlet is not included.
Geography
Where the outlets covering this story are based.
4 unique outletsDominant coverage: Europe
Coverage imbalance
  • Coverage is currently concentrated among outlets based in Europe (4 of 4 geographically-identified sources).
How we measure coverage

How outlets' accounts compare

2 framing differences · 2 uncorroborated claims · 3 information gaps
Sources broadly agree on the core facts but frame the story differently.Compared across 2 reports whose full text Updat3 used; 2 other outlets were checked by headline only.
Framing / emphasis differences
Sources agree on the facts but emphasise different angles, actors or consequences.
  • Daily Record focuses on Goodburn’s emotional appeal and describes his diagnosis as "devastating," while The Independent emphasises the sequence of events (private MRI during Olympic trials) and provides more clinical naming (oligodendroglioma).
  • All substantive medical and treatment claims in the reporting are attributed to Archie Goodburn and his statements to Brain Tumour Research.
Updat3: The underlying facts agree; only the emphasis differs.
One-sided or uncorroborated claims
Claims that come from one party or one source family and are not independently corroborated.
  • Goodburn’s claim that paying for a private MRI led to his cancer diagnosis is reported consistently, but no source independently confirms the diagnostic timeline beyond his account.
  • "Being told you have incurable cancer and have 10 to 12 years to live is devastating," and that taking vorasidenib in summer 2025 was "transformational," both quoted from Goodburn in the supplied sources.
Updat3: Not independently corroborated yet — treat as a claim, not an established fact.
Not established by the reporting
Information the available reporting does not contain or confirm. This is a gap, not a disagreement.
  • No source provides medical records or clinician explanations for the initial migraine diagnosis.
  • No source supplies broader data on UK treatment options or clinical pathways for oligodendroglioma beyond Goodburn’s statements.
  • No source cites regulatory decisions, NHS policy documents, or trial approval statuses that would contextualise Goodburn’s claim about lack of a "plan B."
Updat3: Updat3 cannot conclude anything about this from the current sources.

How we got here

Arch immediately precedes today’s coverage: in 2026 Archie Goodburn made a televised appeal on BBC Breakfast (2026) and publicly called for the UK prime minister to appoint a national brain cancer lead (2026).

Before that appeal, while training for the 2024 Olympic trials Goodburn paid for a private MRI (2024), and he was subsequently diagnosed with an oligodendroglioma at age 22 (diagnosis reported in 2024–2026 sources).

Original sources

5 articles from 4 outlets

Every story links to the reporting it was built from. How we choose sources

Spotted a factual error, a broken link or a misleading summary? Tell us.